在接受声神经瘤手术的患者中发生在术前和术后的恶心和吐:回顾性数据库分析
Martin Krause1, Soraya Mehdipour1, Katelynn Tran2
1Division of Perioperative Informatics, Department of Anesthesiology.
Journal of neurosurgical anesthesiology
|January 22, 2026
概括
在声神经瘤手术患者中,手术前的阿布雷皮坦没有减少手术后的恶心和吐 (PONV). 在手术期间的因素,而不是这种药物,可能会影响PONV风险.
科学领域:
- 神经外科 神经外科
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后恶心和吐 (PONV) 是手术后常见的并发症,影响了康复和患者满意度.
- 与其他骨手术相比,声神经瘤 (AN) 切除带有较高的PONV发病率.
- 研究像阿普雷皮坦特这样的预防性抗药对高风险AN患者的PONV管理至关重要.
研究的目的:
- 评估手术前阿普雷皮坦在声神经瘤切除后减少PONV的疗效.
- 在这个特定人群中确定与PONV风险相关的患者和手术因素.
主要方法:
- 从2017年12月至2022年4月接受AN切除的579名患者的术后数据的回顾性分析.
- 在接受手术前阿普雷皮坦的队列和匹配的对照队列 (1:2比) 之间的比较.
- 用单变量和多变量回归分析来评估PONV结果.
主要成果:
- 49%的患者经历了PONV;手术前的阿布雷皮坦与减少的PONV没有显著的关联 (P=0.239).
- 无变量分析确定了瘤大小,外科手术方法 (跨),醇剂量,晶体体体积,氧化和麻醉时间作为潜在的因素.
- 多变量分析没有证实任何这些因素与PONV几率降低有显著关联.
结论:
- 手术前的阿布雷皮坦在经过声神经瘤手术后缓解PONV方面没有效果.
- 手术方法和麻醉时间可能会影响PONV风险,需要进一步调查.
- 未来的研究应该专注于确定在AN患者中用于PONV预防的新型术后干预措施.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
707
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
707
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
612
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
612
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
831
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
831
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
601
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
601
Pathophysiology of Vomiting
2.8K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.8K
Peripheral Artery Disease V: Postoperative Nursing Management
385
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
385


